Fixed Dose Procedure for Acute Oral Toxicity Testing

Method and main features

The FDP uses a stepwise dosing strategy in which a small group of animals receives a predetermined dose level and is observed for defined clinical signs over a specified period. Typical implementations use relatively few animals (commonly cited totals are about 10–20) rather than the dozens required by historical tests. Observations focus on reversible signs of toxicity — such as changes in behavior, appearance, respiration or motor control — rather than mortality as the primary endpoint. If adverse signs are absent or severe, the procedure may be repeated at an adjusted dose to refine the classification.

Key characteristics

• Stepwise administration of fixed dose levels to small groups of animals.
• Primary endpoint: evident toxicity signs short of death; mortality is avoided if possible.
• Smaller animal numbers and reduced suffering compared with older LD50 tests.
• May require one or more additional cohorts at higher or lower fixed doses to establish a suitable toxicity band.

History and comparison with LD50

The FDP was introduced as a refinement to long-standing methods for acute toxicity testing. The older LD50 test, developed in the early 20th century, aimed to determine the dose that would kill 50% of treated animals and typically used many more animals (often several dozen). Critics of the LD50 highlighted ethical concerns and advocated for approaches that use fewer animals and produce less suffering. The FDP represents one such refinement and has been cited in scientific and regulatory discussions as a means to balance safety assessment needs and animal welfare LD50 background historical note.

Advantages, limitations and regulatory role

Advantages of the FDP include reduced animal use, clearer focus on observable and recoverable toxicity signs, and streamlined classification into hazard categories. Limitations include less precise numeric estimates of lethal dose and the potential need for repeat testing to refine a classification. Over time, variants and alternative methods have been adopted into testing strategies and guidance by some regulatory bodies; practitioners should consult relevant guidance when planning studies. Further methodological background and the original proposal can be found in foundational sources original proposal (1984) and summaries of acute oral testing approaches method overview.

Because testing approaches and regulatory expectations differ between jurisdictions, the FDP is best understood as one option within a spectrum of acute toxicity methods that aim to protect human health while reducing animal suffering. For comparison with other alternatives and current guidance, readers should consult their national or international regulatory documents and technical references further reading.